On this page:OverviewPublicationsKey papers
ScholarIQanswers from OpenAlex & ORCID

Kevan C. Herold

ResearcherPublications, citations & collaboration network

Kevan C. Herold is a researcher indexed in ScholarIQ from OpenAlex & ORCID.

How many works does Kevan C. Herold have?

ScholarIQindexed works

Kevan C. Herold has 444 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

How many citations does Kevan C. Herold have?

ScholarIQcitation count

Kevan C. Herold has 32,974 citations in the OpenAlex counts ScholarIQ stores.

What is the h-index of Kevan C. Herold?

ScholarIQh-index

Kevan C. Herold has an h-index of 92 in OpenAlex.

What is the i10-index of Kevan C. Herold?

ScholarIQi10-index

Kevan C. Herold has an i10-index of 266 in OpenAlex.

What is the ORCID of Kevan C. Herold?

ScholarIQorcid

The ORCID for Kevan C. Herold is on the source record.

What is the OpenAlex record for Kevan C. Herold?

ScholarIQopenalex

The OpenAlex for Kevan C. Herold is on the source record.

What are the most-cited papers on Kevan C. Herold?

ScholarIQmost cited works
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
Richard A. Insel, Jessica L. Dunne, Mark A. Atkinson, Jane L. Chiang, Dana Dabelea, Peter A. Gottlieb, Carla J. Greenbaum, Kevan C. Herold, Jeffrey P. Krischer, Åke Lernmark, Robert E. Ratner, Marian Rewers, Desmond Schatz, Jay S. Skyler, Jay M. Sosenko, Anette‐G. Ziegler
Diabetes Care. 20151,174 CitationsOPEN ACCESS
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
Kevan C. Herold, Brian N. Bundy, S. Alice Long, Jeffrey A. Bluestone, Linda A. DiMeglio, Matthew J. Dufort, Stephen E. Gitelman, Peter A. Gottlieb, Jeffrey P. Krischer, Peter S. Linsley, Jennifer B. Marks, Wayne D. Moore, Antoinette Moran, Henry Rodriguez, William E. Russell, Desmond Schatz, Jay S. Skyler, Eva Tsalikian, Diane K. Wherrett, Anette-Gabriele Ziegler, Carla J. Greenbaum
New England Journal of Medicine. 20191,141 CitationsOPEN ACCESS
C-Peptide Is the Appropriate Outcome Measure for Type 1 Diabetes Clinical Trials to Preserve β-Cell Function
Jerry P. Palmer, G. Alexander Fleming, Carla J. Greenbaum, Kevan C. Herold, Lisa D. Jansa, Hubert Kolb, John M. Lachin, Kenneth S. Polonsky, Paolo Pozzilli, Jay S. Skyler, Michael W. Steffes
Diabetes. 2004488 CitationsOPEN ACCESS
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients
Carl A. Pierce, Paula Preston‐Hurlburt, Yile Dai, Clare Burn Aschner, Natalia Cheshenko, Benjamin Galen, S. Garforth, Natalia G. Herrera, Rohit K. Jangra, Nicholas C. Morano, Erika P. Orner, Sharlene Sy, Kartik Chandran, James Dziura, Steven C. Almo, Aaron M. Ring, Marla J. Keller, Kevan C. Herold, Betsy C. Herold
Science Translational Medicine. 2020393 CitationsOPEN ACCESS
Abnormal neutrophil signature in the blood and pancreas of presymptomatic and symptomatic type 1 diabetes
Federica Vecchio, Nicola Lo Buono, Angela Stabilini, Laura Nigi, Matthew J. Dufort, Susan Geyer, Paola M. V. Rancoita, Federica Cugnata, Alessandra Mandelli, Andrea Valle, Pia Leete, Francesca Mancarella, Peter S. Linsley, Lars Krogvold, Kevan C. Herold, Helena Elding Larsson, Sarah J. Richardson, Noel G. Morgan, Knut Dahl‐Jørgensen, Guido Sebastiani, Francesco Dotta, Emanuele Bosi, the DRI_Biorepository Group, the Type 1 Diabetes TrialNet Study Group, Manuela Battaglia
JCI Insight. 2018218 CitationsOPEN ACCESS

Related on ScholarIQ

470M+ articles · free account